TNFSF11 and thymoma: RANKL was initially identified on murine thymoma cell line EL40.5, and then in 1997, functional genomics and biochemical analyses identified RANKL, expressed by activated T cells, as a stimulator of the DCs (109), and RANKL played an essential role in regulating the DCs–T cells interaction (110).